# Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agents

> **NCT00545467** · PHASE4 · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 79 (actual)

## Conditions studied

- DSM-IV Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** Aripiprazole

## Key facts

- **NCT ID:** NCT00545467
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2009-06
- **Final completion:** 2009-07
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2012-05-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00545467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00545467, "Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agents". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00545467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*